Compare Enveric Biosciences Inc (ENVB) vs Humana Inc (HUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Humana Inc — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Humana Inc trades at $372.16 (market cap $44.77B). The key difference: Humana Inc is far larger — about 7221× Enveric Biosciences Inc's market cap, and Humana Inc pays a 0.95% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | HUM | |
|---|---|---|
Market Cap | $6.20M | $44.77B |
Sector | Health | Health |
52-Week High | $17.40 | $409.42 |
52-Week Low | $1.27 | $163.67 |
Enterprise Value | $1.30M | $52.12B |
Dividend Yield | — | 0.95% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →
